ACC Action Center
Welcome to the ACC Action Center, bringing you the latest updates from the American College of Cardiology’s Annual Scientific Session & Expo, hosted in partnership with the World Congress of Cardiology. This collection will highlight emerging clinical data and explore the latest practice-changing advances in the field of cardiology.
31-45 of 61
More than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia
ACC Action CenterMore than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia
Daniel Gaudet, MD, PhD
Stopping aspirin after 1 month DAPT in ACS patients after stenting
ACC Action CenterStopping aspirin after 1 month DAPT in ACS patients after stenting
Gregg Stone, MD
Head-to-head comparison of two TAVR devices in patients with aortic stenosis and small aortic annuli
ACC Action CenterHead-to-head comparison of two TAVR devices in patients with aortic stenosis and small aortic annuli
Howard C. Herrmann, MD
APOC3 ASO significantly lowers triglycerides in patients with hypertriglyceridemia and high CV risk
ACC Action CenterAPOC3 ASO significantly lowers triglycerides in patients with hypertriglyceridemia and high CV risk
Brian Bergmark, MD
No improvements in CV outcomes at 90 days with human ApoA-1 infusions post-MI
ACC Action CenterNo improvements in CV outcomes at 90 days with human ApoA-1 infusions post-MI
Michael Gibson, MD
Early aggressive lipid-lowering strategy with PCSK9 siRNA performs better than usual care in US patients with ASCVD
ACC Action CenterEarly aggressive lipid-lowering strategy with PCSK9 siRNA performs better than usual care in US patients with ASCVD
Michael Koren, MD
- advertisement
No effect on the primary endpoint with SGLT2i post-MI, but significant effect on HF hospitalizations
ACC Action CenterNo effect on the primary endpoint with SGLT2i post-MI, but significant effect on HF hospitalizations
Javed Butler, MD
Patricia A. Pellikka, M.D.
Closing Gaps in Care for Patients with T2D & CV Disease
Diabetes DiscourseClosing Gaps in Care for Patients with T2D & CV Disease
John Buse, MD, PhD
Jennifer B. Green, MD
Cardio-Oncology: Key Clinical Data from ACC.23
ACC Action CenterCardio-Oncology: Key Clinical Data from ACC.23
Ana Barac, MD, PhD
The Emerging Field of Cardio-Oncology: A Look at the Multidisciplinary Team
ACC Action CenterThe Emerging Field of Cardio-Oncology: A Look at the Multidisciplinary Team
Javed Butler, MD
Ana Barac, MD, PhD
The STELLAR Trial: Key Data on Sotatercept for PAH
ACC Action CenterThe STELLAR Trial: Key Data on Sotatercept for PAH
Marius M. Hoeper, MD
- advertisement
Insights on Statin Therapy & LDL Cholesterol from the CLEAR Outcomes Trial
ACC Action CenterInsights on Statin Therapy & LDL Cholesterol from the CLEAR Outcomes Trial
Kausik Ray, MBChB, MD, MPhil
Social Media & Heart Health: Insights from ACC.23
ACC Action CenterSocial Media & Heart Health: Insights from ACC.23